Skip to main content
KMTS logo

KMTS · Kestra Medical Technologies, Ltd.

Track KMTS — free
$27.26 -0.65 (-2.33%) At close · Aug 20
Market Cap
$1.64B
Shares
58.60M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$27.26 Open$27.49 Day$27.00–28.11 52W close$16.12–28.35 Avg vol 30d346K Short int3.3M · 5.6% float · 10.2d Short vol51% Last earningsJul 14, 2026 DataMar 2025–Aug 2026 Filing10-K · Jul 14

Up next

Next earnings call
Oct 16, 2026 Est · unconfirmed · in 8 wks
FQ2-27 quarter ends
~Oct 30, 2026 Est
filed Jul 14, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Buy
      50 / 200-day cross Golden cross
      Price vs 200-day avg +16%
      above
      Price vs 50-day avg +12%
      above
      RSI (14) 59
      neutral
      MACD trend Positive
      52-week position 91%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +26%
      trailing
      6-month return +17%
      trailing
      YTD return +3%
      this year
      Relative strength +6%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) Golden cross
      50d $24 › 200d $24 — 50d above 200d
      Institutional flow Accumulating
      +5% holders QoQ · +16 funds added
      Insider flow Distributing
      Net -$4.1M over 90 days · 100% sells
      Short interest Rising
      5.62% of float · ▲ +6.4% MoM · 10.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      108 holders — near 1-yr high, broad support
      Squeeze score 82
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +59%
      Y/Y
      Gross margin 51%
      expanding
      EPS growth +53%
      Y/Y
      Free cash flow $-116.6M
      Balance sheet $57.1M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 66%
      annualized · 1-yr
      Max drawdown −36%
      past year
      ATR 5.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 14, 2026
      Revenue · FY27 $137M
      Prior guidance period ended · from the 8-K filed Mar 17, 2026
      FY26 revenue guidance · FY26 $93M
      Guided vs delivered · last 1 settled
      FY26 revenue FY26
      guided $91M
      $95.13M Beat +4.5%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 2 · 5
      50 / 200-day cross
      Golden cross Bullish
      Price vs 200-day avg
      +16% Bullish
      Price vs 50-day avg
      +12% Bullish
      RSI (14)
      59 Neutral
      MACD trend
      Positive Bullish
      52-week position
      91% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) Golden cross
      50d $24 › 200d $24 — 50d above 200d
      Institutional flow Accumulating
      +5% holders QoQ · +16 funds added
      Insider flow Distributing
      Net -$4.1M over 90 days · 100% sells
      Short interest Rising
      5.62% of float · ▲ +6.4% MoM · 10.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      108 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      Range low $16 Now $27 · 91% Range high $28
      vs 200-day avg +16% vs 50-day avg +12% 50-day above 200-day golden cross

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP $87M FY2026
      adjusted operating expenses non-GAAP $144.6M FY2026
      Cash and cash equivalents, and investments $262.2M as of April 30, 2026
      prescriptions were written for the ASSURE® system 5,462 Q3 FY26

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      KMTS
      Kestra Medical Technologies, Ltd.
      this stock
      $1.64B +2.8% +59.0% 5.6%
      ISRG
      Intuitive Surgical Inc
      $140.51B -33.9% +20.5% 45.7 1.9%
      BDX
      Becton Dickinson & Co
      $51.11B +8.2% 3.7%
      MDLN
      Medline Inc.
      $44.58B -22.4% +11.5% 2.6%
      ALC
      Alcon Inc
      $35.25B -7.5% +10.5% 2.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      108
      % held
      100.2%
      Net QoQ
      +267.4K sh
      Top holder
      Bain Capital Investors LLC
      Held Float
      View
      Held by Funds
      Fund positions
      39
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      3.3M
      Days to cover
      10.2d
      Change
      +197.8K sh
      View
      Short Volume
      Short vol %
      51%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      8.7K
      Value
      $207.1K
      As of
      Jul 29, 2026
      View
      Off-Exchange
      Off-exchange %
      42.6%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$4.1M
      Buyers / Sellers
      0 / 5
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $95.1M
      Net income (FY)
      $-131.6M
      EPS diluted
      $-2.43
      View
      Filings
      SEC Filings
      Latest
      DEF 14A
      Filed
      Jul 28, 2026
      This year
      5
      View
      Proposed Sales
      Value
      $412.2K
      Shares
      15.0K
      Filed
      Aug 17, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 14, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      KMTS -1.7% +26.4% +17.1% +19.4% +2.8%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY +0.2% +23.1% +5.9% +17.3% -9.0%
      Key facts CIK 1877184 CUSIP G52441105 13F (30d) 105 filings 104 filers Visit website Investor relations